| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Advances in macrocyclic peptide-based antibiotics
|
Luther, Anatol
|
|
2018
|
26 |
10 |
p. 2850-2858
|
article
|
| 2 |
An opportunistic route to success: Towards a change of paradigm to fully exploit the potential of cell-penetrating peptides
|
Collado Camps, Estel
|
|
2018
|
26 |
10 |
p. 2780-2787
|
article
|
| 3 |
Challenges in the design of insulin and relaxin/insulin-like peptide mimetics
|
Hossain, Mohammed Akhter
|
|
2018
|
26 |
10 |
p. 2827-2841
|
article
|
| 4 |
Editorial Board
|
|
|
2018
|
26 |
10 |
p. ii
|
article
|
| 5 |
Exploiting the human peptidome for novel antimicrobial and anticancer agents
|
Bosso, Matteo
|
|
2018
|
26 |
10 |
p. 2719-2726
|
article
|
| 6 |
Graphical abstract TOC
|
|
|
2018
|
26 |
10 |
p. OBC
|
article
|
| 7 |
Graphical abstract TOC
|
|
|
2018
|
26 |
10 |
p. IBC
|
article
|
| 8 |
Graphical abstract TOC continued
|
|
|
2018
|
26 |
10 |
p. II-VI
|
article
|
| 9 |
Heterocycles: Versatile control elements in bioactive macrocycles
|
Soor, Harjeet S.
|
|
2018
|
26 |
10 |
p. 2774-2779
|
article
|
| 10 |
Improving oral bioavailability of cyclic peptides by N-methylation
|
Räder, Andreas F.B.
|
|
2018
|
26 |
10 |
p. 2766-2773
|
article
|
| 11 |
Machine learning-enabled discovery and design of membrane-active peptides
|
Lee, Ernest Y.
|
|
2018
|
26 |
10 |
p. 2708-2718
|
article
|
| 12 |
Macrocyclic α helical peptide therapeutic modality: A perspective of learnings and challenges
|
Sawyer, Tomi K.
|
|
2018
|
26 |
10 |
p. 2807-2815
|
article
|
| 13 |
Nose-to-brain peptide delivery – The potential of nanotechnology
|
Samaridou, Eleni
|
|
2018
|
26 |
10 |
p. 2888-2905
|
article
|
| 14 |
Optimization of peptide-based polyagonists for treatment of diabetes and obesity
|
Knerr, Patrick J.
|
|
2018
|
26 |
10 |
p. 2873-2881
|
article
|
| 15 |
Peptide chemistry toolbox – Transforming natural peptides into peptide therapeutics
|
Erak, Miloš
|
|
2018
|
26 |
10 |
p. 2759-2765
|
article
|
| 16 |
Peptides for optical medical imaging and steps towards therapy
|
Staderini, Matteo
|
|
2018
|
26 |
10 |
p. 2816-2826
|
article
|
| 17 |
Peptide Therapeutics
|
Vorherr, Thomas
|
|
2018
|
26 |
10 |
p. 2699
|
article
|
| 18 |
Peptide therapeutics for the treatment of gastrointestinal disorders
|
Fretzen, Angelika
|
|
2018
|
26 |
10 |
p. 2863-2872
|
article
|
| 19 |
Peptide therapeutics from venom: Current status and potential
|
Pennington, Michael W.
|
|
2018
|
26 |
10 |
p. 2738-2758
|
article
|
| 20 |
Peroral peptide delivery: Peptidase inhibition as a key concept for commercial drug products
|
Werle, Martin
|
|
2018
|
26 |
10 |
p. 2906-2913
|
article
|
| 21 |
Personalized neoantigen vaccines: A new approach to cancer immunotherapy
|
Aldous, Amanda R.
|
|
2018
|
26 |
10 |
p. 2842-2849
|
article
|
| 22 |
Prospects of PASylation® for the design of protein and peptide therapeutics with extended half-life and enhanced action
|
Gebauer, Michaela
|
|
2018
|
26 |
10 |
p. 2882-2887
|
article
|
| 23 |
Ribosomally-synthesised cyclic peptides from plants as drug leads and pharmaceutical scaffolds
|
Craik, David J.
|
|
2018
|
26 |
10 |
p. 2727-2737
|
article
|
| 24 |
Seek & Destroy, use of targeting peptides for cancer detection and drug delivery
|
Le Joncour, Vadim
|
|
2018
|
26 |
10 |
p. 2797-2806
|
article
|
| 25 |
Synthetic peptide API manufacturing: A mini review of current perspectives for peptide manufacturing
|
Rasmussen, Jon H.
|
|
2018
|
26 |
10 |
p. 2914-2918
|
article
|
| 26 |
Teixobactin as a scaffold for unlimited new antimicrobial peptides: SAR study
|
Abdel Monaim, Shimaa A.H.
|
|
2018
|
26 |
10 |
p. 2788-2796
|
article
|
| 27 |
Therapeutic peptides for CNS indications: Progress and challenges
|
Morimoto, Bruce H.
|
|
2018
|
26 |
10 |
p. 2859-2862
|
article
|
| 28 |
Therapeutic peptides: Historical perspectives, current development trends, and future directions
|
Lau, Jolene L.
|
|
2018
|
26 |
10 |
p. 2700-2707
|
article
|
Journal description